Why This Webinar?

The Japanese pharmaceutical market is the second leading market globally. Though it is a mature market like the US and Europe, it has its own unique characteristics and regulatory requirements. Entering such a new market by exploring “on your own”, poses great challenges that could not only result in slow-down of the process but also regulatory risks for your clinical studies.

This webinar focuses on an overview of the Japanese pharmaceutical market, its unique characteristics, regulatory updates and market entry options. Through several case studies, our industry experts provide you with step-by-step guidance on what to look out for and how to  ensure a successful market entry.

This 60 minute session includes

Overview of current Japanese pharmaceutical market
Highlights of recent  Regulatory Changes
Case Studies: Key Steps to ensure a successful market entry

A 45-minute informative session on

Followed by a 15-minute Q&A

The Speaker Panel

Copyright 2018 Marcus Evans - Your Webinar Broadcaster

Dr. Gregg Mayer
President
Gregg L. Mayer & Company, Inc.

Lucy Sha
SVP, Corporate Development Division
CMIC Holdings Co., Ltd.

Lucy Sha is the current Senior VP of Corporate Development for CMIC Holdings, Japan's largest CRO with a broader business scope such as CDMO, CSO, SMO, etc. Lucy is responsible for driving the US business growth and corporate development bridging the US and Asia market. Before this role, she was the Head of Marketing and Commercial Development for Catalent Asia Pacific. Lucy has 15+ years commercial experience across life sciences, medical devices and pharmaceutical industry. She had led and managed teams across the US, Europe and Asia Pacific region, and excelled at multiple new business initiatives globally and in emerging markets.

Dr. Gregg Mayer received his BA and PhD from the University of California, Berkeley. After serving as the President at Berkeley Antibody Company, and Vivigen, Inc., he studied Japanese at Keio University in Tokyo and was also a research student at Keio University Business School. He joined the San Francisco office of McKinsey & Company, and then left to establish his own management consulting practice. He has spent the last 22 years focusing on healthcare business strategy in the US and Japan, and has helped numerous US companies with their development strategies in Japan.

View Webinar Material
View Webinar Material

A Complimentary Webinar

Tips to Ensure Market Entry Success in Japan

Challenges, Regulatory Updates and Success Factors